Store

Home | Store | Hematology and Coagulation Markets, 2023

Hematology and Coagulation Markets, 2023

Publication Date: April 5, 2023

SKU: 23-708

Tags: Coagulation, Diagnostic Instruments, Hematology, In Vitro Diagnostics (IVD)

Pages: 75

SKU: 23-708

Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.

 

Key Insights Provided:

  • Market sizing for Hematology IVD and Coagulation IVD
  • Markets for Decentralized and Lab-based Segments
  • Forecasts to 2027
  • Market Share

 

Country Markets Covered:

Explore individual country markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) and Coagulation (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States).

 

In-depth Analysis:

Hematology: Hematology testing plays a vital role in diagnosing blood-related diseases such as leukemias, anemia, and autoimmune disorders. The report covers essential tests like complete blood count (CBC) and its components, highlighting the industry’s shift towards automation and IT solutions.

Coagulation: The report explores the complexities of hemostasis (coagulation) and its role in regulating blood flow and clot formation. It discusses the increasing demand for reliable and efficient hemostasis testing solutions, particularly in managing anticoagulant therapies and preventing clot-related conditions.

 

Market Data:

All market data are based on factory sales to end-users, providing a direct insight into market size and dynamics. The report presents market segments in U.S. dollar values, reflecting the number of tests performed and the associated costs.

 

Stay Ahead of the Curve!

As the market for hematology and coagulation IVD testing continues to evolve, Kalorama’s report offers essential insights to help you navigate this dynamic landscape and capitalize on emerging opportunities. Order your copy today to unlock the full potential of this growing market.

 

Table: Coagulation Diagnostic Sales, by Test Category, 2022 ($ millions)

 Test Category 2022 $ % Mkt
D-dimer $XX Million XX%
PT/INR Lab $XX Million XX%
Thrombophilia SNP $XX Million XX%
POC Coagulation $XX Million XX%
Total $XX Million XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.

Table of Contents

Chapter 1:  Executive Summary

Hematology Market Overview

Hematology Market Sales

  • Figure 1-1: Global Hematology Testing Market by Product Segment (Lab-based Hematology and Decentralized [POC] Hematology), 2022-2027 ($ million)
  • Figure 1-2: Global Hematology Testing Market by Product Segment (Lab-based Hematology and Decentralized [POC] Hematology), 2022-2027 (% market)

Coagulation Market Overview

Coagulation Market Sales

  • Figure 1-3: Coagulation Diagnostic Sales by Test Category, 2022 (D-dimer, PT/INR, Thrombophilia SNP, POC) ($ millions)
  • Figure 1-4: Coagulation Diagnostic Sales by Test Category, 2022 (D-dimer, PT/INR, Thrombophilia SNP, POC) (%)

Recent Developments in Hematology and Coagulation

Developments

Scope and Methodology

Chapter 2: Focus on Hematology

Overview of Hematology

Market Outlook

  • Figure 2-1: Global Hematology Testing Market by Product Segment (Lab-based Hematology and POC Hematology), 2022-2027 ($ million)
  • Table 2-2: Lab-Based and Decentralized Hematology Market Summary
  • Figure 2-2: Hematology Analyzer/Instrument FDA CLIA Amendments by Year, 2000-2022
  • Figure 2-3: Hematology Analyzer/Instrument Market Share, by Top Vendor (Abbott, Beckman Coulter, Becton Dickinson, EKF, Horiba, Mindray, Roche, Siemens, Sysmex, Others), 2022 (%)

Chapter 3: Focus on Coagulation

Overview of Diagnostics in Coagulation

Market Outlook

  • Table 3-1: Coagulation Diagnostic Sales by Test Category, 2022 (D-dimer, PT/INR, Thrombophilia SNP, POC) ($ millions)
  • Figure 3-1: Coagulation Diagnostic Sales by Broad Test Category, 2017-2022 ($ millions)

Major Product Activity

PT/INR

Thrombophilia SNP

D-dimer

POC Coagulation

  • Figure 3-2: POC Coagulation Testing Market Distribution (Professional, Home/Patient), 2022 (%)

Laboratory vs. Point-of-Care Markets

  • Figure 3-3: Coagulation Testing Market by End Use Setting (Laboratory, Point-of-Care), 2017-2027

Chapter 4: International Regional Trends

Regional Hematology Market

  • Table 4-1: Hematology Analyzer/Reagent Market by Region (North America, Europe, Asia Pacific, ROW), 2022-2027 ($ millions)
  • Figure 4-1: Hematology Analyzer/Reagent Market by Setting and Region (Asia Pacific, Europe, North America, ROW), 2022-2027 ($ millions)

Regional Coagulation Market

  • Table 4-2: Coagulation Diagnostic Test Sales Distribution by Global Region, 2022 (Asia Pacific, Europe, North America, ROW) (%)

Country-Level Hematology and Coagulation Market

  • Figure 4-2: Global Market for Hematology, by Select Country (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States), 2022-2027 ($ millions)
  • Figure 4-3: Global Market for Coagulation PT/INR, by Select Country (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States), 2022-2027 ($ millions)

Australia

  • Table 4-3: Australia Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Brazil

  • Table 4-4: Brazil Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Canada

  • Table 4-5: Canada Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

China

  • Table 4-6: China Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

France

  • Table 4-7: France Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Germany

  • Table 4-8: Germany Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

India

  • Table 4-9: India Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Italy

  • Table 4-10: Italy Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Japan

  • Table 4-11: Japan Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Spain

  • Table 4-12: Spain Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Turkey

  • Table 4-13: Turkey Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

United Kingdom

  • Table 4-14: United Kingdom Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

United States

  • Table 4-15: US Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)

Chapter 5: Corporate Profiles

Top Hematology and Coagulation Company Briefs

Abbott Diagnostics

Hematology

Abingdon Health Ltd.

Beckman Coulter, Inc. / Danaher

Hematology

Hematology IT

Biotype Diagnostic GmbH

BioView Ltd.

CellaVision AB

Danaher

Diagnostica Stago S.A.S.

EKF Diagnostics Holdings Plc

ELITech Group S.A.S.

Grifols S.A.

Coagulation

Horiba Medical

Instrumentation Laboratory (IL) / Werfen

Coagulation

Mast Group

Menarini Diagnostics

Mindray – Shenzhen Mindray Bio-medical Electronics Co., Ltd.

Nihon Kohden

Nova Biomedical

Roche Diagnostics

Hematology

Coagulation

Sekisui Diagnostics LLC

Siemens Healthineers (Siemens)

Hematology

Streck Inc.

Sysmex Corporation

Hematology

Coagulation

Our Knowledge Center provides access to

all market reports